The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 26 of the 28 sources its claims cite were checked for support.
Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase
Open accessPreprint — published as 10.1038/s41586-023-06990-w · Paper page
Abstract
Bacteria in the gastrointestinal tract (GI) produce a variety of amino acid bile acid amidates that impact host-mediated metabolic processes; however, the bacterial gene(s) responsible for their production remain unknown. Herein, we report that bile salt hydrolase (BSH) possesses dual functions, including a new role in bile acid metabolism by functioning as an amine N-acyl transferase that conjugates amines to form bacterial bile acid amidates (BBAAs). To characterize this new amine N-acyl transferase role for BSH, we used pharmacological inhibition of BSH, heterologous expression of bsh in Escherichia coli, and generated a bsh knockout and knockin in Bacteroides fragilis to demonstrate that BSH is necessary and sufficient for BBAA production. Lastly, we report that BBAAs activate host ligand-activated transcription factors including the farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and the aryl hydrocarbon receptor. These new findings expand our understanding and appreciation for the important roles that bacteria play in shaping the bile acid metabolic network.
Overview
CoChat Summary
TL;DR
The paper reports that bacterial bile salt hydrolase (BSH) has a previously unknown amine N-acyltransferase activity that conjugates amines to bile acids, forming bacterial bile acid amidates (BBAAs), in addition to its canonical deconjugation role. It links BSH/bsh to BBAA production in bacterial isolates, gnotobiotic mice, and human infants, and shows BBAAs can activate host nuclear receptors in cell and organoid models.
Key findings
- BSH is necessary and sufficient for BBAA formation: the pan-BSH inhibitor GR-7 reduced BBAA production; purified BlBSH synthesized BBAAs from CA or TCA; E. coli expressing BlBSH produced BBAAs; B. fragilis Δbsh eliminated BBAA production from CA/TCA and complementation rescued it.
- bsh presence was significantly associated with BBAA production across combined isolate datasets (P = 9.4 × 10−6, phylogenetic linear regression); in B. longum, bsh was upregulated by CA/DCA (RNA-seq log2FC = 2.14, adjusted P = 6.52 × 10−85; RT-qPCR 2.7-fold, P = 0.0026).
- In germ-free mice monocolonized with B. fragilis WT vs Δbsh, Δbsh-colonized mice had depleted BBAA levels (P = 3.1 × 10−4) and altered primary bile acids; free caecal taurine was higher in WT-colonized mice (P = 4.27 × 10−4).
- In a human infant cohort (n = 108), BBAA levels increased from 0–4 days to 12 months; Enterococcus abundance positively correlated with BBAAs, and Bifidobacterium with His/Thr conjugates. BBAAs activated host receptors: Glu-conjugated bile acids activated FXR, CAR3, PXR, AHR and PPARα (P < 0.0001); mouse organoids upregulated Cyp3a11, Cyp1a1 and Bsep, and human organoids upregulated CYP1A1 with 100 µM Glu-CDCA (P < 0.01).
Methods
- Combined LC–MS/MS BBAA data from two published bacterial isolate datasets (202 HMP isolates and 69 representative gut bacteria) with genomes; used phylogenetic linear regression to test bsh–BBAA association; performed RNA-seq and RT-qPCR in B. longum NCTC 11818.
- Used purified BlBSH enzyme assays, heterologous expression and site-directed mutagenesis in E. coli, B. fragilis NCTC 9343 Δbsh and complementation, and germ-free C57BL/6J mice monocolonized with WT or Δbsh B. fragilis (n = 7 WT, n = 8 Δbsh) with LC–MS/MS and 1H NMR.
- Human infant IGRAM cohort stool samples (56 male, 52 female) at birth, 1 month, and 12 months; shotgun metagenomics and LC–MS/MS; cell-based reporter assays for FXR, VDR, CAR3, PXR, AHR, PPARα/β/δ/γ and mouse/human enteroid qPCR.
Limitations
- Stated: the conjugation mechanism is unclear; human organoid responses were less pronounced than mouse; further in vitro and in vivo studies are required to show whether BBAAs affect metabolism of substrates, drugs and carcinogens regulated by PXR and AHR; future studies must re-evaluate BBAA contribution to disease outcomes related to BSH activity.
- Evident from the text: receptor activation evidence is largely cell culture/organoid, not in vivo; human infant findings are observational correlations; mouse work uses monocolonization with one B. fragilis strain, so generalizability to complex microbiota is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
7 Valid · 2 Not valid · 2 Not checked · 45 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Some BBAAs activate host bile acid nuclear receptors like the farnesoid X receptor (FXR) and pregnane X receptor (PXR)1,3, but an assessment of other receptors has not been completed.”
§ Bile salt hydrolase catalyses formation of amine-conjugated bile acids > Main
What the sources say
- Partly supportedcites [1] Quinn RA Global chemical effects of the microbiome include new bile-acid conjugations Nature 2020 579 123 129 10.1038/s41586-020-2047-9 32103176 PMC7252668 sourceExperimental — accuracy not yet measured
The “Novel Bile Acids and FXR” section reports that phenylalanine- and tyrosine-conjugated bile acids activate human FXR in a cell-based assay. The passages in our copy do not report activation of PXR, so the citation supports the FXR part but not the PXR part. (LLM, conf=0.88)
- Partly supportedcites [3] Gentry, E. C. et al. Reverse metabolomics for the discovery of chemical structures from humans. Nature10.1038/s41586-023-06906-8 (2023). PMC10849969 38052229 sourceExperimental — accuracy not yet measured
The 'Validation of the IBD association' section reports that several conjugated bile acids act as PXR agonists and that two increased PXR activation in intestinal organoids. Our copy does not report that BBAAs activate FXR; FXR appears only in the title of a cited reference, not as a finding of this paper. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As there are hundreds of different BSHs found in microbiota that synthesize different BBAAs3, BSHs may be instrumental in fine tuning different pathways that promote health or disease.”
§ Bile salt hydrolase catalyses formation of amine-conjugated bile acids > Conclusion
What the sources say
- Could not verifycites [3] Gentry, E. C. et al. Reverse metabolomics for the discovery of chemical structures from humans. Nature10.1038/s41586-023-06906-8 (2023). PMC10849969 38052229 sourceExperimental — accuracy not yet measured
The Microbial production of bile amides section reports that bacteria produce some conjugated bile acids, and Validation of the IBD association reports immune activity for several conjugates. But the copy does not say that BSHs synthesize different BBAAs or fine-tune health- or disease-related pathways; searches for “BSH” and “bile salt hydrolase” found only a reference-list entry. (LLM, conf=0.73)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: unclear — It is unclear whether it could be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Bacteria in the gastrointestinal tract produce amino acid bile acid amidates that can affect host-mediated metabolic processes1–6; however, the bacterial gene(s) responsible for their production remain unknown.”
§ Bile salt hydrolase catalyses formation of amine-conjugated bile acids > Abstract
What the sources say
- Supportedcites [1] Quinn RA Global chemical effects of the microbiome include new bile-acid conjugations Nature 2020 579 123 129 10.1038/s41586-020-2047-9 32103176 PMC7252668 source
In “Microbes produce the novel bile acids,” the paper reports that gut bacterium C. bolteae synthesized amino-acid–conjugated bile acids. “Novel Bile Acids and FXR” reports that these conjugates stimulate human FXR in a cell-based system and reduce expression of liver genes involved in bile-acid production when administered to mice. The paper also says the microbial enzyme responsible remains unknown. (LLM, conf=0.93)
- Supportedcites [2] Lucas LN Dominant bacterial phyla from the human gut show widespread ability to transform and conjugate bile acids mSystems 2021 6 e00805 e00821 10.1128/mSystems.00805-21 PMC12338150 34463573 source
The Results and Discussion section reports that gut bacteria conjugate bile acids to amino acids and that certain resulting conjugates can act as FXR agonists. The Introduction identifies FXR as a host receptor involved in regulating metabolic processes. The paper notes that the physiological effects of most other amino-acid conjugates remain unknown. (LLM, conf=0.85)
- Supportedcites [3] Gentry, E. C. et al. Reverse metabolomics for the discovery of chemical structures from humans. Nature10.1038/s41586-023-06906-8 (2023). PMC10849969 38052229 source
The “Microbial production of bile amides” section reports that bacterial cultures produced amino-acid conjugates of bile acids. The “Validation of the IBD association” section reports that several of these conjugates activate the host PXR receptor, which the paper describes as involved in metabolism, and that two increased expression of a downstream target gene (pages not provided). (LLM, conf=0.90)
- Partly supportedcites [4] Hoffmann MA High-confidence structural annotation of metabolites absent from spectral libraries Nat. Biotechnol. 2022 40 411 421 10.1038/s41587-021-01045-9 34650271 PMC8926923 sourceExperimental — accuracy not yet measured
In Results, ‘Searching for novel bile acid conjugates’ (page unavailable), the paper describes amino-acid bile acid conjugates produced by microbes and suggests microbial involvement in producing additional conjugates. It says bile acids act as signaling molecules, but does not establish that the amino-acid conjugates affect host-mediated metabolic processes. (LLM, conf=0.84)
- Partly supportedcites [5] Funabashi M A metabolic pathway for bile acid dehydroxylation by the gut microbiome Nature 2020 582 566 570 10.1038/s41586-020-2396-4 32555455 PMC7319900 sourceExperimental — accuracy not yet measured
The Abstract says gut bacteria produce the secondary bile acids DCA and LCA, which modulate host metabolism. It does not say they produce amino acid bile acid amidates or that those amidates affect host metabolic processes; the paper addresses a different class of bile acid products. (LLM, conf=0.84)
- Partly supportedcites [6] Aatsinki, A.-K. et al. Dynamics of gut metabolome and microbiome maturation during early life. Preprint at medRxiv10.1101/2023.05.29.23290441 (2023). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says microbial transformation of bile acids can regulate human physiology, and the Discussion (page unavailable) links bile acids to metabolic processes. Neither passage says gut bacteria produce amino acid bile acid amidates specifically; the Discussion instead describes bacterial deconjugation of glycine from bile acids. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“However, the greater diversity of BBAAs produced by purified BlBSH in vitro (Fig. 2b) compared to BlBSH-expressing E. coli (Fig. 2c) is probably a result of the different amino acid profiles in E. coli (alanine is present at about a 100-fold greater concentration than serine)23.”
§ Bile salt hydrolase catalyses formation of amine-conjugated bile acids > BSH is a bacterial N-acyltransferase
What the sources say
- Could not verifycites [23] Bennett BD Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli Nat. Chem. Biol. 2009 5 593 599 10.1038/nchembio.186 19561621 PMC2754216 sourceExperimental — accuracy not yet measured
The Results and Discussion describe measurements of E. coli metabolite concentrations, but the passages found for “alanine,” “serine,” and their concentration ratio give no values for either amino acid. Our copy therefore does not verify the approximately 100-fold comparison for which this paper is cited. (LLM, conf=0.73)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Most of the BBAA activators of the human bile acid receptor FXR were conjugates of CDCA (5 of 8, P < 0.0001), probably reflecting the potency of CDCA as an FXR agonist26.”
§ Bile salt hydrolase catalyses formation of amine-conjugated bile acids > BBAAs activate host transcription factors To demonstrate potential biological relevance of BSH-mediated BBAA production, we assessed in cell culture models the activation of VDR, CAR3, PXR and AHR in a cell-based reporter assay (Extended Data Fig. 7). Most of the BBAA activators of the human bile acid receptor FXR were conjugates of CDCA (5 of 8, P < 0.0001), probably reflecting the potency of CDCA as an FXR agonist26. Bile acids conjugated with glutamate activated human FXR, CAR3, PXR, AHR and PPARα (P < 0.0001). Therefore, we selected Glu-CA and Glu-CDCA for further exploration in organoid models. We treated organoids cultured from mouse and human small intestinal crypts with 50 µM or 100 µM Glu-CA or Glu-CDCA and measured the expression of FXR, CAR, PXR and AHR target genes. In mouse organoids, Glu-CA and Glu-CDCA upregulated Cyp3a11, Cyp1a1 and Bsep expression, indicating that PXR and AHR were transcriptionally activated (Extended Data Figs. 8a and 9a). Responses in human organoids were less pronounced, but CYP1A1 expression was also upregulated with 100 µM Glu-CDCA treatment (P < 0.01, Extended Data Figs. 8b and 9b). We previously showed that Glu-conjugated bile acids were activators of human PXR in vitro14, and herein, we observed activation of AHR by both bacterially conjugated and conventional bile acids in vitro. Further studies, both in vitro and in vivo, are required to demonstrate whether BBAAs affect the metabolism of substrates, drugs and carcinogens regulated by PXR26 and AHR27.
What the sources say
- Supportedcites [26] Li T Chiang JYL Nuclear receptors in bile acid metabolism Drug Metab. Rev. 2013 45 145 155 10.3109/03602532.2012.740048 23330546 PMC3676171 source
The citation is attached to the explanation that CDCA is a strong FXR agonist, not to the citing paper’s 5-of-8 count or P value. The “Bile-acid–activated nuclear receptors” section says CDCA is the most efficacious FXR ligand among bile acids and gives its EC50 as approximately 10 μM. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
28 more claims
Create a free account to see all 56 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, these data suggest that BSHs are involved in MCBA production; indeed, other studies are already investigating the possibility of BSH-catalysed reconjugation46,47.”
From Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut (2023) · cites this paper as [46]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, BSH activity is complicated by the emerging data indicating that these enzymes can catalyse reconjugation to generate MCBAs capable of activating host ligand-activated receptors31,33,46,47.”
From Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut (2023) · cites this paper as [46]
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Twelve years of SAMtools and BCFtools
Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab008 · Cited by 15,343
Kraken: ultrafast metagenomic sequence classification using exact alignments
Wood, D. E., & Salzberg, S. L. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r46 · Cited by 4,521
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Okonechnikov, K., Conesa, A., & García-Alcalde, F. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv566 · Cited by 2,145
Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli
Bennett, B. D., Kimball, E. H., Gao, M., Osterhout, R., Van Dien, S. J., & Rabinowitz, J. D. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.186 · Cited by 1,830
Cited by
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 326
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Mohanty, I., Allaband, C., Mannochio-Russo, H., El Abiead, Y., Hagey, L. R., Knight, R., & Dorrestein, P. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00914-3 · Cited by 218
“…acts as a substrate for BSH from the bacterial species Lactobacillus spp., Enterocloster bolteae (formerly Clostridium bolteae ), Bifidobacterium longum and Bacteroides fragilis to furnish amino acid-conjugated bile acids, as highlighted by representative examples from the literature 42,158 (Fig.”
InfluentialSelf-citationThe underappreciated diversity of bile acid modifications
Mohanty, I., Mannochio-Russo, H., Schweer, J. V., El Abiead, Y., Bittremieux, W., Xing, S., Schmid, R., Zuffa, S., Vasquez, F., Muti, V. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.019 · Cited by 202
“35,38 The BSHs, from Bacteroides fragilis , Clostridium perfringens , and Lactobacillus species, known to catalyze the hydrolysis of taurocholate and glycocholate, have now also been shown to possess amino-transferase activities.”
InfluentialSelf-citationFoley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Patel, S., Beaty, V. V., Allen, G., Pan, M., Simpson, J. B., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01337-7 · Cited by 181
Self-citation
Metadata
- Authors
- Patterson, A., Rimal, B., Collins, S., Granda, M., Koo, I., Solanka, S., Hoque, N., Gentry, E., Yan, T., Bisanz, J., Krausz, K., Desai, D., Amin, S., Rocha, E., Coleman, J., Shah, Y., Gonzalez, F., Heuvel, J. V., Dorrestein, P., & Weinert, E.
- Affiliations
- Pennsylvania State University (US)
- University of Michigan
- University of California San Diego (US)
- National Institutes of Health (US)
- East Carolina University (US)
- University of Michigan (US)
- Penn State University
- Corresponding author
- Patterson, Andrew
- ORCID
- Venue
- Nature
- Published
- 2022-10-10
- Volume
- 626
- Issue
- 8000
- Pages
- 859-863
- ISSN
- 0028-0836 (ISSN-L)
- PMC
- PMC10881385
- OpenAlex
- W4391616565
- Cited by
- 252
- References
- 49
- Citations by year
- 2026: 99 · 2025: 88 · 2024: 60 · 2023: 5
- FWCI
- 28.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature (publishedVersion, cc-by)
- Research Square (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Agriculture (1009993, U01DK119702)
- American Heart Association (19POST34380588)
- Pennsylvania Department of Health (UL1TR001878)
- Children's Hospital of Philadelphia (UL1TR001878)
- University of Pennsylvania (P30 DK050306)
- University of Michigan (DK034933, P30CA046592, P50CA130810)
- Pennsylvania State University
- Crohn's and Colitis Foundation (675191, 623914)
- American Beverage Foundation for a Healthy America
- National Institutes of Health (1s10od021750-01a1, 1009993, PEN047702, UL1TR001878)
- University of Michigan Comprehensive Cancer Center (P30 CA046592)
- National Cancer Institute (R01CA245546, P50CA130810, P30CA046592, R01CA148828)
- National Institute of General Medical Sciences (R01GM125842, R35GM138369, T32GM102057, R35GM151045)
- National Institute of Allergy and Infectious Diseases (R00AI147165)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, U01DK119702, T32DK120509, R01DK095201, R01DK136117, U24DK133658, P30DK050306, R01DK107565)
- National Institute of Environmental Health Sciences (R35ES035027)
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- bile salt hydrolase, bile acid metabolism, Bacteroides fragilis, gut microbiota, infant gut colonization, pregnane X receptor, aryl hydrocarbon receptor, ligand-activated transcription factors, Escherichia coli
- MeSH terms
- Gastrointestinal Microbiome, Pregnane X Receptor, Acyltransferases, Amidohydrolases, Amines, Bacteroides fragilis, Bile Acids and Salts, Escherichia coli, Humans, Infant, Ligands, Transcription Factors, Cohort Studies, Receptors, Aryl Hydrocarbon, Cell Culture Techniques, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase. https://app.cochat.ai/papers/10.21203/rs.3.rs-2050120/v1
- The paper
- Patterson, A., Rimal, B., Collins, S., Granda, M., Koo, I., Solanka, S., Hoque, N., Gentry, E., Yan, T., Bisanz, J., Krausz, K., Desai, D., Amin, S., Rocha, E., Coleman, J., Shah, Y., Gonzalez, F., Heuvel, J. V., Dorrestein, P., & Weinert, E. (2022). Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase. Nature. https://doi.org/10.21203/rs.3.rs-2050120/v1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.